DocuSign — FQ1 FY2027 Earnings Review
Most Recent Quarter: FQ1 FY2027 (ended April 30, 2026; reported Thursday June 4, 2026 AMC) ·
Stock $47.26 (June 5 intraday, -7.2% post-print from $50.94) ·
~$9.2B market cap · Analysis date: June 5, 2026 · FYE late January ·
Fundamentals via FMP / company filings (Daloopa MCP not connected this run)
Total Revenue
$830.2M
+8.7% YoY (~+7% ex-FX; +1.6pp FX benefit) · BEAT — above $826M guide high · vs $824.7M cons (+0.7%)
Non-GAAP EPS
$1.09
+21% YoY (vs $0.90) · BEAT vs ~$1.00 cons (+$0.09 / +9%) · GAAP EPS $0.40 (+18%)
Non-GAAP Op Margin
32.0%
+250bps YoY (vs 29.5%) · +275bps above guide midpoint · Op income $266M (+18%)
FY27 Revenue Guide
$3.490-3.502B
RAISED ~$6M at midpoint · +9% YoY · Op margin guide raised +50bps to 30.5-31.0%
Verdict: A clean beat-and-raise that the market hated. Revenue cleared the high end of guide, non-GAAP EPS beat by $0.09 (+9%), op margin came in 275bps above the guide midpoint, and DocuSign raised both the FY27 revenue and operating-margin guides while posting its largest buyback ever ($318M). Yet the stock fell ~7% to $47. Why: this was the smallest beat of the multi-quarter streak, the +8.7% headline carried a +1.6pp FX tailwind (so ~+7% organic — a slight FX-adjusted deceleration QoQ that analysts pressed on directly), billings/subscription "looked a little lighter than normal," and management did not raise the +8.5% ARR growth guide — leaving the entire "fiscal 2027 is the acceleration year" thesis back-half-loaded and still unproven. The bottom line is excellent (margin + capital return); the top-line re-acceleration the bulls need has not yet arrived.
What Changed vs Last Quarter (Q4 FY26, Mar 17): (1) IAM stepped up to 12.6% of total ARR from 10.8% last quarter (+180bps QoQ), with 40,000 companies now on the platform; management reaffirmed IAM reaching ~18% of ARR (>$600M) by FY27 year-end. (2) FY27 revenue guide nudged up to $3.490-3.502B (was $3.484-3.496B) — only ~$6M at the midpoint, i.e. flowing through roughly the Q1 beat, not a fundamental raise. (3) FY27 non-GAAP op-margin guide raised +50bps to 30.5-31.0% (was 30.0-30.5%) — the clearest positive revision, reflecting cloud-migration costs peaking and disciplined headcount (net adds skewed to low-cost locations). (4) Dollar net retention >102%, up >1pp YoY and now improving sequentially for 7 straight quarters. (5) Largest buyback in company history — $318M repurchased (vs $269M in Q4), $2.4B authorization remaining; FY27 diluted share count guided to 191-193M. (6) FCF margin jumped to 35% (from 30% YoY) — $289M FCF. (7) New Anthropic MCP-connector partnership announced at the Momentum event drew "thousands" of beta sign-ups. (8) Crucially, the ARR growth guide held at +8.5% — not raised — which is what disappointed a Street that had priced in an early upgrade to the acceleration story.
Key Metrics Trends — Quarterly (9 Quarters)
| Metric | Q1'25 | Q2'25 | Q3'25 | Q4'25 | Q1'26 | Q2'26 | Q3'26 | Q4'26 | Q1'27 |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue ($M) | 709.6 | 736.0 | 754.8 | 776.3 | 763.7 | 800.6 | 818.4 | 836.9 | 830.2 |
| Revenue YoY % | +7.4% | +6.8% | +7.7% | +9.0% | +7.6% | +8.8% | +8.4% | +7.8% | +8.7% |
| Ex-FX Revenue YoY % (est.) | — | — | — | — | ~+8% | ~+9% | ~+8% | ~+7% | ~+7.1% |
| Non-GAAP Diluted EPS | $0.82 | $0.97 | $0.90 | $0.86 | $0.90 | $0.92 | $1.01 | $1.01 | $1.09 |
| Non-GAAP EPS YoY % | — | — | — | — | +9.8% | -5.2% | +12.2% | +17.4% | +21.1% |
| GAAP Diluted EPS | $0.16 | $4.26* | $0.30 | $0.39 | $0.34 | $0.30 | $0.40 | $0.44 | $0.40 |
| Diluted Shares (M) | 209.9 | 208.3 | 208.7 | 210.3 | 212.8 | 211.9 | 210.6 | 204.7 | 196.5 |
Revenue held the +7-9% YoY band for a 9th straight quarter — durable, not accelerating. The +8.7% Q1'27 print includes a +1.6pp FX tailwind, so organic growth was ~+7% — a touch slower than recent quarters on an FX-neutral basis, the crux of the bear pushback. The real progress is below the top line: non-GAAP EPS re-accelerated to +21% YoY on op-margin expansion plus a ~7.7% YoY reduction in diluted share count from record buybacks. *Q2'25 GAAP EPS of $4.26 reflects a one-time deferred-tax-valuation-allowance release, not operating performance. Source: FMP / company filings; FY = late-January year-end.
Key Metrics Trends — Annual (5 Years + FY27 Guide)
| Metric (FYE late-Jan) | FY22 | FY23 | FY24 | FY25 | FY26 | FY27E (guide) |
|---|---|---|---|---|---|---|
| Total Revenue ($M) | 2,107 | 2,516 | 2,762 | 2,977 | 3,219 | ~3,496 |
| Revenue YoY % | — | +19.4% | +9.8% | +7.8% | +8.1% | +8.6% |
| Non-GAAP Diluted EPS | n/a | n/a | n/a | $3.55 | $3.84 | ~$4.40 |
| Non-GAAP EPS YoY % | — | — | — | — | +8.2% | ~+15% |
| GAAP Op Income ($M) | (62) | (88) | 32 | 200 | 299 | — |
The multi-year arc: hyper-growth (+19% FY23) gave way to a durable high-single-digit plateau (+8% FY24-FY27E) — DocuSign is now a steady-grower, not a grower-accelerator, and the FY27 guide (+8.6%) extends that plateau. The transformation since FY24 is on the profit line: GAAP operating income swung from a $(88)M loss (FY23) to +$299M (FY26), and non-GAAP EPS is set to step up ~+15% in FY27 on margin expansion + buyback despite flat-ish revenue growth. Non-GAAP EPS for FY22-24 not shown (not reconstructed). Source: FMP annual income statements; FY27 from company guide. FY25 GAAP net income distorted by a one-time deferred-tax valuation-allowance release.
KPI Snapshot — Operating Drivers (Q1 FY27)
| Driver | Q1 FY27 | Trend | Read |
|---|---|---|---|
| IAM % of total ARR | 12.6% | 10.8% → 12.6% QoQ (+180bps); 40,000 companies | On track to ~18% / >$600M ARR by FY27 year-end |
| Dollar Net Retention | >102% | +1pp+ YoY; 7th straight quarter of sequential gains | Slow, steady expansion — bottoming behind it |
| Total Customers | ~1.9M | +9% YoY | Steady base growth |
| International Revenue Mix | 31% | Intl growth accelerated ~10% → ~17% YoY | Fastest-growing geography; above company average |
| Free Cash Flow / Margin | $289M / 35% | Up from 30% margin YoY | High-quality conversion; collections + expense control |
| Buyback / Authorization | $318M / $2.4B | Largest quarterly repurchase in company history | ~7.7% YoY share-count reduction; primary EPS lever |
| Balance Sheet | ~$1.0B cash | No debt | Clean; fully funds buyback from FCF |
| Envelope Consumption | Multiyear highs | Envelopes sent up YoY; consumption rose in Q1 | Rebuts "eSignature is being disrupted by AI" |
Beat / Miss Analysis
This Quarter vs Consensus & Guide
| Metric | Guide (Mar 17) | Consensus | Actual | Result |
|---|---|---|---|---|
| Total Revenue | $822-826M | $824.7M | $830.2M | BEAT +0.7% (above high end) |
| Non-GAAP Op Margin | 29.0-29.5% | ~29.2% | 32.0% | BEAT +275bps vs mid |
| Non-GAAP Gross Margin | ~81.0% | ~81.0% | 81.5% | BEAT +50bps |
| Non-GAAP EPS | n/a (rev-only guide) | ~$1.00 | $1.09 | BEAT +$0.09 / +9% |
| Free Cash Flow | — | — | $289M (35% mgn) | STRONG (+500bps mgn YoY) |
Management explanation for the margin upside: CFO Blake Grayson attributed the +275bps op-margin beat versus guide to "4 different components, each with generally similar impacts" — the revenue beat dropping through, favorable expense timing, disciplined hiring (net adds concentrated in lower-cost locations), and the back end of the on-prem-to-cloud data-center migration completing (the bulk of the migration cost headwind is now behind the company). The flip side, and the reason the stock fell: the revenue beat (+0.7%) was the narrowest of the recent streak. Robbie Owens (Piper) said it directly — "the beat probably wasn't as big as you've seen historically" — and Patrick Walravens (Citizens) pushed that on an FX-adjusted basis growth "maybe actually decelerated a little bit quarter-to-quarter." Management's defense: Q1 is seasonally the smallest quarter, billings/FCF timing is volatile, and the ARR re-acceleration is a back-half-weighted FY27 story.
Beat History (Revenue vs Consensus, Last 6 Quarters)
| Quarter | Rev Beat | Status |
|---|---|---|
| Q4 FY25 | ~+1.5% | Beat |
| Q1 FY26 | ~+1.3% | Beat |
| Q2 FY26 | ~+1.4% | Beat |
| Q3 FY26 | ~+1.2% | Beat |
| Q4 FY26 | ~+1.3% | Beat |
| Q1 FY27 | +0.7% | Beat (smallest) |
Pattern: consistent revenue beater, but magnitude compressed to +0.7% this quarter — the slimmest of the run — against a high investor bar. EPS beat magnitude, by contrast, expanded (+9% vs ~+6-7% prior) on margin and buyback. Beat percentages prior to Q1 FY27 are approximate, reconstructed from reported actuals vs the prevailing Street midpoint at each print.
Guidance Deep Dive
| Metric | New Guide | Midpoint YoY | vs Prior Guide |
|---|---|---|---|
| Q2 FY27 — Revenue | $865-869M | ~+8% | New (harder comp — Q2 was FY26's fastest quarter) |
| Q2 FY27 — Non-GAAP Gross Margin | 81.5-81.7% | Down slightly YoY | New |
| Q2 FY27 — Non-GAAP Op Margin | 29.7-30.2% | Expansion YoY | New |
| FY27 — Revenue | $3.490-3.502B | ~+9% | RAISED ~$6M at mid (was $3.484-3.496B) |
| FY27 — Non-GAAP Gross Margin | 81.5-82.0% | Down slightly YoY | Maintained |
| FY27 — Non-GAAP Op Margin | 30.5-31.0% | +50bps vs FY26 | RAISED +50bps at mid (was 30.0-30.5%) |
| FY27 — ARR Growth | ~+8.5% | Accel vs FY26 | UNCHANGED — not raised |
| FY27 — Diluted Shares | 191-193M | ~-5% YoY | Buyback > offsets dilution |
| FY27 — IAM % of ARR (year-end) | ~18% (>$600M) | From 12.6% today | Reaffirmed |
The guidance tell: the op-margin raise (+50bps) is genuine and well-supported — cloud-migration costs are rolling off and the company is holding headcount discipline. But the revenue raise was cosmetic (~$6M, roughly the size of the Q1 beat), and the +8.5% ARR growth guide was explicitly left unchanged. When Tyler Radke (Goldman) asked whether management felt "incrementally more confident in that 8.5% versus 90 days ago," Allan Thygesen leaned positive but stopped short of raising it. For a stock whose entire bull thesis is "FY27 = the acceleration year," holding the ARR guide steady after a Q1 that was "fine" rather than "great" is what re-rated the multiple lower. The acceleration is now entirely a 2H FY27 event that has to be taken on faith.
Street Q&A — Key Exchanges
| Analyst | Question | Mgmt Response | Grade |
|---|---|---|---|
| Patrick Walravens (Citizens) | 3.5 years in — "I'd love to have seen you in double digits by now. On an FX-adjusted basis maybe you decelerated a bit QoQ. What's been harder than expected?" | Acknowledged the multi-year turnaround takes time; pointed to IAM "clearly working," DNR inflecting, and the platform shift as the path to double digits — without committing to a timeline. | Honest, not fully satisfying |
| Robbie Owens (Piper Sandler) | Shape of the quarter — "the beat wasn't as big as you've seen historically… without a discrete subscription number, walk us through the bookings." | Blake: billings "came in just as we expected," billings is volatile/de-emphasized; pointed to last year's Q1 billings +4% vs full-year +9.5% as evidence Q1 timing isn't predictive. | Well answered |
| Michael Turrin (Wells Fargo) | Anthropic & other LLM partnerships — how is DocuSign positioned vs what the LLMs themselves are building? | Allan: "unprecedented" inbound on the MCP-connector announcement (thousands of beta sign-ups); DocuSign's 200M+ consented-agreement corpus + workflow context is the moat generic LLMs lack. | Well answered |
| Tyler Radke (Goldman Sachs) | Are you incrementally more confident in the +8.5% ARR guide vs 90 days ago? Should IAM % progress linearly to ~18%? | Leaned positive on ARR conviction but did not raise the guide; IAM mix builds with some 2H seasonality as deals move upmarket. | Constructive but guarded |
| Brent Thill (Jefferies) | International accelerating from ~10% to ~17% — what's driving it and what's left? | Allan: strong demand across all regions for the IAM platform; personally heading to Europe; runway remains large as IAM rolls out internationally. | Well answered |
Indirect Read-Throughs
Company / Ecosystem Mentions
| Entity | Relationship | Read-Through |
|---|---|---|
| Anthropic | Partner / AI | MCP-connector partnership drew "thousands" of beta sign-ups — positive validation of agentic-agreement demand and of MCP as a distribution surface for vertical SaaS. |
| Deloitte | SI partner | New Deloitte study cited quantifying IAM's value in eliminating fragmented agreement handoffs — large-SI channel "increasingly emphasizing IAM." |
| CLM vendors (Ironclad, Sirion, Icertis, etc.) | Competitors | Management acknowledged encountering CLM vendors in competitive deals but argued DocuSign's distribution + end-to-end IAM platform out-positions point CLM products. |
| LLM platforms (ChatGPT / general agents) | Potential disruptor | Framed as complementary, not threatening — moat is the 200M+ private consented-agreement corpus + workflow + identity layer the LLMs don't have. |
Macro Commentary
Management characterized the demand environment as stable and consistent — no incremental macro deterioration called out, no notable deal-cycle elongation. The +1.6pp FX tailwind to revenue was flagged as a known benefit (USD weakness). International strength (~17% growth) suggests no regional demand air-pockets. Net read-through for software peers: a steady, unremarkable enterprise-spend backdrop — neither the reacceleration bulls hoped for nor the deterioration bears feared. The DocuSign-specific story (IAM transition, margin self-help, capital return) is doing the work, not the macro.
Contradictions
No hard contradictions found across the prepared remarks, Q&A, and prior-quarter framing. The one tension worth flagging: management continues to assert FY27 will be "the acceleration year" for ARR, yet (a) held the +8.5% ARR growth guide unchanged after Q1, and (b) conceded under questioning that on an FX-adjusted basis revenue growth ticked slightly lower QoQ. These are reconcilable — the acceleration is explicitly back-half-weighted as IAM mix climbs toward ~18% — but the burden of proof now sits squarely on Q3/Q4 FY27, and the consistency of the "accelerating" language against a still-sub-10% organic growth rate is the gap the market is discounting.
Upcoming Catalysts
| Catalyst | Timing | What to Watch |
|---|---|---|
| Q2 FY27 print | ~early Sept 2026 | Revenue vs $865-869M against the hard YoY comp; first read on whether the 2H ARR acceleration is materializing; IAM % of ARR progress toward 18%. |
| IAM ARR ramp to >$600M | Through FY27 | Whether IAM mix climbs linearly (12.6% → ~18%); HR/Procurement SKU traction; enterprise-cohort consumption uplift vs non-IAM customers. |
| Anthropic / MCP-connector GA | 2H FY27 | Conversion of "thousands" of beta sign-ups into paid agentic-agreement usage — proof the AI-distribution channel monetizes. |
| Buyback cadence | Ongoing | $2.4B authorization remaining (~26% of float at ~$9.2B cap); record $318M pace at a depressed ~$47 stock is a meaningful EPS tailwind into FY27/28. |
| Cloud-migration completion | FY27 | Bulk of on-prem→cloud site migrations now done; gross-margin headwind rolling off supports the raised op-margin trajectory. |
Bottom line: DocuSign delivered exactly the kind of quarter that looks great on the scorecard and trades down anyway. Beat on revenue (above guide high), beat on EPS (+$0.09), beat on margin (+275bps), raised the FY27 revenue and op-margin guides, posted a record buyback, and showed IAM stepping up to 12.6% of ARR with DNR improving for a 7th straight quarter. The bottom-line/capital-return machine is firing on all cylinders. But the market wanted evidence of top-line re-acceleration, and Q1 didn't provide it: the smallest beat of the streak, a +1.6pp FX flatter underneath, and — most importantly — an ARR growth guide that management pointedly declined to raise. At ~$47 (~11x forward non-GAAP P/E on ~$4.40 FY27 EPS, ~8x EV/FCF on ~$8.2B EV), DOCU is priced for the acceleration not to come; the stock works if 2H FY27 ARR actually inflects, and the buyback is doing real per-share work in the meantime. The setup into Q2 is now show-me.
Sources: DocuSign FQ1 FY2027 earnings call transcript & press release (June 4, 2026) via Financial Modeling Prep; quarterly income statements via FMP; consensus baseline from the FY2027Q1 preview. Daloopa MCP was not connected for this scheduled run — fundamentals sourced from FMP and company filings. Prepared June 5, 2026.